Do analysts prefer ISPO or DFNS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspirato 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Nukkleus 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Is ISPO or DFNS more profitable?

Nukkleus has a net margin of 0.00% compared to Inspirato's net margin of -4.24%. Inspirato's return on equity of 0.00% beat Nukkleus' return on equity. Company Net Margins Return on Equity Return on Assets Inspirato -4.24% N/A -4.10% Nukkleus N/A -190.60% -40.70%

Do analysts rate IBAC or DFNS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IB Acquisition 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Nukkleus 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Which has better valuation and earnings, IBAC or DFNS?

Nukkleus has higher revenue and earnings than IB Acquisition. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IB Acquisition N/A N/A N/A N/A N/A Nukkleus $5.91M 0.79 $78.55M -$2.94 N/A

Is IBAC or DFNS more profitable?

IB Acquisition's return on equity of 0.00% beat Nukkleus' return on equity. Company Net Margins Return on Equity Return on Assets IB Acquisition N/A N/A N/A Nukkleus N/A -190.60% -40.70%

Does the media refer more to IBAC or DFNS?

In the previous week, Nukkleus had 1 more articles in the media than IB Acquisition. MarketBeat recorded 6 mentions for Nukkleus and 5 mentions for IB Acquisition. IB Acquisition's average media sentiment score of 0.62 beat Nukkleus' score of -0.02 indicating that IB Acquisition is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IB Acquisition 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nukkleus 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer LOAN or DFNS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Manhattan Bridge Capital 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Nukkleus 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50

Do analysts prefer DFNS or FSP?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nukkleus 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50 Franklin Street Properties 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts rate DFNS or FTII?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nukkleus 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50 FutureTech II Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger valuation & earnings, DFNS or FTII?

Nukkleus has higher revenue and earnings than FutureTech II Acquisition. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nukkleus $5.91M 0.79 $78.55M -$2.94 N/A FutureTech II Acquisition N/A N/A N/A N/A N/A

Is DFNS or FTII more profitable?

FutureTech II Acquisition's return on equity of 0.00% beat Nukkleus' return on equity. Company Net Margins Return on Equity Return on Assets Nukkleus N/A -190.60% -40.70% FutureTech II Acquisition N/A N/A N/A

Nukkleus (DFNS) Competitors

$0.05 -0.02 (-28.86%)

As of 07/16/2026 04:00 PM Eastern

Compare

DFNS vs. ISPO, IBAC, LOAN, FSP, and FTII

Should you buy Nukkleus stock or one of its competitors? MarketBeat compares Nukkleus with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Nukkleus include Inspirato (ISPO), IB Acquisition (IBAC), Manhattan Bridge Capital (LOAN), Franklin Street Properties (FSP), and FutureTech II Acquisition (FTII). These companies are all part of the "trading" industry.

How does Nukkleus compare to Inspirato?

Inspirato (NASDAQ:ISPO) and Nukkleus (NASDAQ:DFNS) are both small-cap trading companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, analyst recommendations, profitability, institutional ownership and valuation.

39.5% of Inspirato shares are held by institutional investors. Comparatively, 12.5% of Nukkleus shares are held by institutional investors. 50.0% of Inspirato shares are held by company insiders. Comparatively, 22.1% of Nukkleus shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Inspirato has a beta of -0.03, suggesting that its stock price is 103% less volatile than the broader market. Comparatively, Nukkleus has a beta of -5.82, suggesting that its stock price is 682% less volatile than the broader market.

In the previous week, Nukkleus had 6 more articles in the media than Inspirato. MarketBeat recorded 6 mentions for Nukkleus and 0 mentions for Inspirato. Inspirato's average media sentiment score of 0.00 beat Nukkleus' score of -0.02 indicating that Inspirato is being referred to more favorably in the media.

Company	Overall Sentiment
Inspirato	Neutral
Nukkleus	Neutral

Nukkleus has lower revenue, but higher earnings than Inspirato. Inspirato is trading at a lower price-to-earnings ratio than Nukkleus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspirato	$247.65M	0.22	-$5.39M	-$0.87	N/A
Nukkleus	$5.91M	0.79	$78.55M	-$2.94	N/A

Nukkleus has a net margin of 0.00% compared to Inspirato's net margin of -4.24%. Inspirato's return on equity of 0.00% beat Nukkleus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspirato	-4.24%	N/A	-4.10%
Nukkleus	N/A	-190.60%	-40.70%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspirato	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Nukkleus	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

Summary

Inspirato beats Nukkleus on 8 of the 15 factors compared between the two stocks.

How does Nukkleus compare to IB Acquisition?

IB Acquisition (NASDAQ:IBAC) and Nukkleus (NASDAQ:DFNS) are both small-cap trading companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, risk and profitability.

IB Acquisition's return on equity of 0.00% beat Nukkleus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IB Acquisition	N/A	N/A	N/A
Nukkleus	N/A	-190.60%	-40.70%

In the previous week, Nukkleus had 1 more articles in the media than IB Acquisition. MarketBeat recorded 6 mentions for Nukkleus and 5 mentions for IB Acquisition. IB Acquisition's average media sentiment score of 0.62 beat Nukkleus' score of -0.02 indicating that IB Acquisition is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IB Acquisition	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Nukkleus	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IB Acquisition	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Nukkleus	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

Nukkleus has higher revenue and earnings than IB Acquisition.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IB Acquisition	N/A	N/A	N/A	N/A	N/A
Nukkleus	$5.91M	0.79	$78.55M	-$2.94	N/A

12.5% of Nukkleus shares are held by institutional investors. 22.1% of Nukkleus shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Nukkleus beats IB Acquisition on 6 of the 9 factors compared between the two stocks.

How does Nukkleus compare to Manhattan Bridge Capital?

Manhattan Bridge Capital (NASDAQ:LOAN) and Nukkleus (NASDAQ:DFNS) are both small-cap trading companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, earnings, media sentiment, profitability, institutional ownership and dividends.

Manhattan Bridge Capital has a beta of 0.14, indicating that its stock price is 86% less volatile than the broader market. Comparatively, Nukkleus has a beta of -5.82, indicating that its stock price is 682% less volatile than the broader market.

Nukkleus has lower revenue, but higher earnings than Manhattan Bridge Capital. Nukkleus is trading at a lower price-to-earnings ratio than Manhattan Bridge Capital, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Manhattan Bridge Capital	$8.67M	5.83	$5.11M	$0.44	10.05
Nukkleus	$5.91M	0.79	$78.55M	-$2.94	N/A

Manhattan Bridge Capital has a net margin of 59.24% compared to Nukkleus' net margin of 0.00%. Manhattan Bridge Capital's return on equity of 11.59% beat Nukkleus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Manhattan Bridge Capital	59.24%	11.59%	7.89%
Nukkleus	N/A	-190.60%	-40.70%

21.8% of Manhattan Bridge Capital shares are held by institutional investors. Comparatively, 12.5% of Nukkleus shares are held by institutional investors. 24.6% of Manhattan Bridge Capital shares are held by company insiders. Comparatively, 22.1% of Nukkleus shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Nukkleus had 4 more articles in the media than Manhattan Bridge Capital. MarketBeat recorded 6 mentions for Nukkleus and 2 mentions for Manhattan Bridge Capital. Manhattan Bridge Capital's average media sentiment score of 0.29 beat Nukkleus' score of -0.02 indicating that Manhattan Bridge Capital is being referred to more favorably in the media.

Company	Overall Sentiment
Manhattan Bridge Capital	Neutral
Nukkleus	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Manhattan Bridge Capital	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Nukkleus	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50

Summary

Manhattan Bridge Capital beats Nukkleus on 11 of the 15 factors compared between the two stocks.

How does Nukkleus compare to Franklin Street Properties?

Nukkleus (NASDAQ:DFNS) and Franklin Street Properties (NYSE:FSP) are both small-cap trading companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

Nukkleus has a beta of -5.82, indicating that its share price is 682% less volatile than the broader market. Comparatively, Franklin Street Properties has a beta of 0.84, indicating that its share price is 16% less volatile than the broader market.

12.5% of Nukkleus shares are held by institutional investors. Comparatively, 61.4% of Franklin Street Properties shares are held by institutional investors. 22.1% of Nukkleus shares are held by company insiders. Comparatively, 4.9% of Franklin Street Properties shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Nukkleus has a net margin of 0.00% compared to Franklin Street Properties' net margin of -43.90%. Franklin Street Properties' return on equity of -7.79% beat Nukkleus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nukkleus	N/A	-190.60%	-40.70%
Franklin Street Properties	-43.90%	-7.79%	-5.30%

Nukkleus has higher earnings, but lower revenue than Franklin Street Properties. Franklin Street Properties is trading at a lower price-to-earnings ratio than Nukkleus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nukkleus	$5.91M	0.79	$78.55M	-$2.94	N/A
Franklin Street Properties	$106.28M	0.47	-$52.72M	-$0.32	N/A

In the previous week, Nukkleus had 6 more articles in the media than Franklin Street Properties. MarketBeat recorded 6 mentions for Nukkleus and 0 mentions for Franklin Street Properties. Franklin Street Properties' average media sentiment score of 0.80 beat Nukkleus' score of -0.02 indicating that Franklin Street Properties is being referred to more favorably in the news media.

Company	Overall Sentiment
Nukkleus	Neutral
Franklin Street Properties	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nukkleus	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Franklin Street Properties	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Nukkleus beats Franklin Street Properties on 8 of the 15 factors compared between the two stocks.

How does Nukkleus compare to FutureTech II Acquisition?

Nukkleus (NASDAQ:DFNS) and FutureTech II Acquisition (NASDAQ:FTII) are both small-cap trading companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, risk, earnings, analyst recommendations and profitability.

Nukkleus has higher revenue and earnings than FutureTech II Acquisition.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nukkleus	$5.91M	0.79	$78.55M	-$2.94	N/A
FutureTech II Acquisition	N/A	N/A	N/A	N/A	N/A

FutureTech II Acquisition's return on equity of 0.00% beat Nukkleus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nukkleus	N/A	-190.60%	-40.70%
FutureTech II Acquisition	N/A	N/A	N/A

Nukkleus has a beta of -5.82, indicating that its stock price is 682% less volatile than the broader market. Comparatively, FutureTech II Acquisition has a beta of -0.03, indicating that its stock price is 103% less volatile than the broader market.

In the previous week, Nukkleus had 6 more articles in the media than FutureTech II Acquisition. MarketBeat recorded 6 mentions for Nukkleus and 0 mentions for FutureTech II Acquisition. FutureTech II Acquisition's average media sentiment score of 0.00 beat Nukkleus' score of -0.02 indicating that FutureTech II Acquisition is being referred to more favorably in the news media.

Company	Overall Sentiment
Nukkleus	Neutral
FutureTech II Acquisition	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nukkleus	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
FutureTech II Acquisition	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

12.5% of Nukkleus shares are held by institutional investors. Comparatively, 65.8% of FutureTech II Acquisition shares are held by institutional investors. 22.1% of Nukkleus shares are held by company insiders. Comparatively, 9.3% of FutureTech II Acquisition shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Nukkleus and FutureTech II Acquisition tied by winning 5 of the 10 factors compared between the two stocks.

Get Nukkleus News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DFNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DFNS vs. The Competition

Export

Metric	Nukkleus	Technology Services Industry	Business Sector	NASDAQ Exchange
Market Cap	$6.57M	$3.77B	$6.83B	$12.67B
Dividend Yield	N/A	2.17%	3.08%	8.87%
P/E Ratio	-0.02	33.19	28.70	24.06
Price / Sales	0.79	40.74	344.47	112.08
Price / Cash	0.02	35.16	23.19	59.89
Price / Book	-0.07	4.00	5.67	6.23
Net Income	$78.55M	$31.76M	$203.59M	$331.94M
7 Day Performance	N/A	-4.87%	-1.52%	-1.66%
1 Month Performance	N/A	-9.81%	-2.50%	-1.03%
1 Year Performance	N/A	-2.73%	10.94%	17.09%

Nukkleus Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DFNS Nukkleus	1.457 of 5 stars	$0.05 -28.9%	N/A	-99.4%	$6.57M	$5.91M	N/A	12	News Coverage Analyst Revision
ISPO Inspirato	N/A	$4.26 flat	N/A	N/A	$53.80M	$247.65M	N/A	770
IBAC IB Acquisition	N/A	$10.72 +0.2%	N/A	+3.2%	$53.71M	N/A	N/A	N/A	News Coverage
LOAN Manhattan Bridge Capital	1.5087 of 5 stars	$4.69 +3.3%	N/A	-19.6%	$53.61M	$8.67M	10.66	6	High Trading Volume
FSP Franklin Street Properties	N/A	$0.51 -0.7%	N/A	-71.1%	$52.98M	$106.28M	N/A	30

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DFNS) was last updated on 7/17/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nukkleus (DFNS) Competitors

DFNS vs. ISPO, IBAC, LOAN, FSP, and FTII

How does Nukkleus compare to Inspirato?

Summary

How does Nukkleus compare to IB Acquisition?

Summary

How does Nukkleus compare to Manhattan Bridge Capital?

Summary

How does Nukkleus compare to Franklin Street Properties?

Summary

How does Nukkleus compare to FutureTech II Acquisition?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DFNS vs. The Competition

Nukkleus Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Nukkleus (DFNS) Competitors

DFNS vs. ISPO, IBAC, LOAN, FSP, and FTII

How does Nukkleus compare to Inspirato?

Do institutionals & insiders have more ownership in ISPO or DFNS?

Which has more volatility and risk, ISPO or DFNS?

Does the media favor ISPO or DFNS?

Which has stronger earnings & valuation, ISPO or DFNS?

Is ISPO or DFNS more profitable?

Do analysts prefer ISPO or DFNS?

Summary

How does Nukkleus compare to IB Acquisition?

Is IBAC or DFNS more profitable?

Does the media refer more to IBAC or DFNS?

Do analysts rate IBAC or DFNS?

Which has better valuation and earnings, IBAC or DFNS?

Do insiders and institutionals believe in IBAC or DFNS?

Summary

How does Nukkleus compare to Manhattan Bridge Capital?

Which has more risk and volatility, LOAN or DFNS?

Which has preferable earnings and valuation, LOAN or DFNS?

Is LOAN or DFNS more profitable?

Do insiders and institutionals have more ownership in LOAN or DFNS?

Does the media refer more to LOAN or DFNS?

Do analysts prefer LOAN or DFNS?

Summary

How does Nukkleus compare to Franklin Street Properties?

Which has more risk & volatility, DFNS or FSP?

Do insiders & institutionals have more ownership in DFNS or FSP?

Is DFNS or FSP more profitable?

Which has stronger valuation and earnings, DFNS or FSP?

Does the media refer more to DFNS or FSP?

Do analysts prefer DFNS or FSP?

Summary

How does Nukkleus compare to FutureTech II Acquisition?

Which has stronger valuation & earnings, DFNS or FTII?

Is DFNS or FTII more profitable?

Which has more risk & volatility, DFNS or FTII?

Does the media prefer DFNS or FTII?

Do analysts rate DFNS or FTII?

Do institutionals and insiders believe in DFNS or FTII?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DFNS vs. The Competition

Nukkleus Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools